Conjupro Biotherapeutics
Princeton, US · Delaware corporation
Conjupro Biotherapeutics is a biopharmaceutical company conducting clinical research and drug development for oncology, cardiology, and CNS diseases. Founded in 2017 as a subsidiary of CSPC Pharmaceutical Company Ltd., it is based in Princeton, NJ.
Founders & leadership
HW
Haixing WangNamed on SEC filing
QW
Qingxi WangNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$9.3M disclosed across 1 round · 2023
▶$9.3MraisedSep 2023 · 1 investors · OtherRule 506(b)
▶$9.3MraisedSep 2023 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Haixing WangExecutive Officer
- Qingxi WangExecutive Officer, Director
- Offering amount
- $67.5M
- Amount sold
- $9.3M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapGlobaldata5 shared keywordsGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
Baidu5 shared keywordsChina's leading search engine and AI technology company
Perplexity5 shared keywordsAn AI-powered answer engine providing accurate, trusted, and real-time answers to questions.
Bioworld4 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Conjupro Biotherapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Conjupro Biotherapeutics do?
- Conjupro Biotherapeutics is a biopharmaceutical company conducting clinical research and drug development for oncology, cardiology, and CNS diseases. Founded in 2017 as a subsidiary of CSPC Pharmaceutical Company Ltd., it is based in Princeton, NJ.
- How much funding has Conjupro Biotherapeutics raised?
- Conjupro Biotherapeutics has disclosed $9.3M raised across 1 round.
- Where is Conjupro Biotherapeutics headquartered?
- Conjupro Biotherapeutics is headquartered in Princeton, US.